Prothena Corp. Plc (PRTA)
10.33
+0.46
(+4.66%)
USD |
NASDAQ |
Dec 11, 16:00
10.39
+0.06
(+0.58%)
Pre-Market: 08:52
Prothena EPS Diluted (Quarterly): -0.6788 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Amarin Corp. Plc | -0.3702 |
| Jazz Pharmaceuticals Plc | 4.081 |
| Iterum Therapeutics Plc | -0.196 |
| GH Research Plc | -0.226 |
| Mural Oncology Plc | -0.214 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -36.54M |
| Revenue (Quarterly) | 2.415M |
| Total Expenses (Quarterly) | 38.96M |
| Enterprise Value | 234.30M |
| Gross Profit Margin (Quarterly) | 60.95% |
| Profit Margin (Quarterly) | -1.51K% |
| Earnings Yield | -50.44% |
| Normalized Earnings Yield | -46.27 |